Edesa Biotech (EDSA) Assets (2013 - 2026)

Edesa Biotech has disclosed Assets across 14 years of filings, most recently posting $12.7 million for Q2 2026.

• In Q2 2026, Assets fell 14.07% year-over-year to $12.7 million; the TTM figure through Jun 2026 stood at $12.7 million (down 14.07% YoY), while the FY2025 annual figure was $13.5 million, up 254.76% from the prior year.
• Assets came in at $12.7 million for Q2 2026 at Edesa Biotech, down from $14.7 million in the prior quarter.
• In the past five years, Assets ranged from a high of $20.4 million in Q1 2022 to a low of $3.8 million in Q3 2024.
• Average Assets over 5 years is $11.2 million, with a median of $11.6 million recorded in 2022.
• Year-over-year, Assets slumped 57.1% in 2024 and surged 254.76% in 2025.
• Over 5 years, Assets stood at $11.7 million in 2022, then tumbled by 32.92% to $7.8 million in 2023, then sank by 46.83% to $4.2 million in 2024, then soared by 253.26% to $14.7 million in 2025, then dropped by 13.52% to $12.7 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $12.7 million in Q2 2026, $14.7 million in Q4 2025, and $13.5 million in Q3 2025.